FindTrial
Sign In

tiapride

DRUG3 trials

Sponsors

Universitair Medisch Centrum Groningen, Tasly Pharmaceuticals, Inc., Hannover Medical School

Conditions

Anxiety DisordersChronic Tic DisorderDementiaDepressionHAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosisPsychosomatic DisordersSchizophreniaTic Disorder

Phase 3

Phase III Study of 5LGr to Treat Tic Disorder
CompletedNCT01501695
Tasly Pharmaceuticals, Inc.Chronic Tic Disorder, Tic Disorder, Tourette Syndrome
Start: 2008-01-31End: 2011-10-31Updated: 2012-12-12
Pharmacovigilance in Gerontopsychiatric Patients
TerminatedNCT02374567
Hannover Medical SchoolAnxiety Disorders, Dementia, Depression +2
Start: 2015-01-31End: 2017-06-28Updated: 2018-02-28

Phase 4

HAMLETT; Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A pragmatic single blind RCT of continuation versus discontinuation/ dose reduction of antipsychotic medication in patients remitted after a first episode of psychosis
Not yet recruitingCTIS2024-518769-80-00
Universitair Medisch Centrum GroningenHAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose reduction/discontinuation.
Target: 444Updated: 2024-11-25

Related Papers

A proprietary herbal medicine (5‐ <scp>L</scp> ing <scp>G</scp> ranule) for <scp>T</scp> ourette syndrome: a randomized controlled trial
Journal of Child Psychology and Psychiatry2015-06-1366 citations